A New Host Strain-Plasmid Combination
A New Core of CLD and Microbial Optimization
At KBI Biopharma, our PUREplatform™ is everything you need to make a protein. Containing plasmids, strains, media, and a fermentation process that all fit together into a service package, catered to your needs. This new core completes our microbial offering from premium cell line development through to late-stage and commercial manufacturing.
- Features our PUREcoli™ cell line, our proprietary high-producing E. coli cell line, expertly paired with PUREplasmids™ and PUREmedia™ available in 8, 48, and 96 screening packages
- Leverages 10+ years of E. coli-based optimization and upstream development
- Designed for secreted proteins, including antibody fragments (FABs), inclusion bodies (IBs), and soluble intracellular molecules
- Robust fermentation conditions that scale from high-throughput 1 mL microfermentations
- Built for small- and large-scale cGMP manufacturing
- Reduces cost of goods, improves efficiencies, and compresses development timelines
- FDA/EMA Inspected Facilities
- Well-versed in first-in-human (FIH) studies, late-stage manufacturing, and commercialization
Strain development was just the start of our mission. To support biopharmaceutical development and fermentation production, our platform targets product quality, safety, and titer across proteins and at scale.
PUREcoli™
PURE in. PURE out.
Learn more about how to jump-start your microbial program with PUREcoli™ to greatly reduce impurities and reach higher titers.
